Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


May 05, 2015 7:38 AM ET

Healthcare Equipment and Supplies

Company Overview of AccessClosure, Inc.

Company Overview

AccessClosure, Inc., a medical device company, designs, manufactures, and distributes access site management devices to address complex challenges in cardiovascular and peripheral vascular markets. The company offers MynxGrip Vascular Closure Device, an extravascular device that is used to seal femoral artery access sites; and Flash Ostial System Dual Balloon Angioplasty Catheter to help overcome the challenges of aorto-ostial stenting. It offers its products through its direct sales force in the United States; and a network of distributors internationally. The company was founded in 2002 and is based in Santa Clara, California. As of May 9, 2014, AccessClosure, Inc. operates as a subsidiary...

5452 Betsy Ross Drive

Santa Clara, CA 95054

United States

Founded in 2002

Phone:

408-610-6500

Fax:

408-610-6701

Key Executives for AccessClosure, Inc.

Chief Executive Officer, President and Director
Age: 57
Co-Founder and Chairman
Chief Financial Officer
Vice President of Operations
Executive Vice President of Regulatory & Quality Affairs
Compensation as of Fiscal Year 2014.

AccessClosure, Inc. Key Developments

AccessClosure Inc. Launches Mynx Ace Vascular Closure Device

AccessClosure Inc. has commercially launched its Mynx Ace Vascular Closure Device, a safe and secure vascular closure product that provides consistent results with a new, easy-to-use deployment system1 to seal femoral artery access sites. The device joins the pioneering line of Mynx extravascular products that help care teams reduce time to hemostasis and ambulation in patients who have undergone diagnostic or interventional endovascular procedures. Mynx closure devices are designed for patient comfort by providing gentle vascular closure without the use of cinching, sutures, or metal implants to enhance patient satisfaction and keep physicians on patient care.2 With Mynx Ace, physicians can consistently close femoral artery access sites through a simple, three-step deployment system. The Mynx Ace system uses AccessClosure's proprietary Grip Technology, a major advancement in sealant technology. Grip Technology employs an extravascular sealant that actively adheres to the artery for safe and secure mechanical closure and dissolves within 30 days, leaving nothing behind in the healed vessel.

Federal Court Shuts Down Janzen Patent Infringement Claim Against AccessClosure, Inc

AccessClosure Inc. has announced that the U.S. Court of Appeals for the Federal Circuit denied a request by St. Jude Medical Inc. to rehear an appeal on a double patenting ruling concerning its U.S. Patent No. 7,008,439, covering technologies to close holes in arteries. The U.S. Court of Appeals' decision, holding the Janzen 439 patent invalid, supports the original jury verdict on Dec. 21, 2010 in the U.S. District Court for the Western District of Arkansas. The U.S. Court of Appeals will send the case back to the Texarkana District Court on December 16, 2013, when it issues its mandate.

AccessClosure, Inc. Announces Distribution Agreement with Ostial Corporation

AccessClosure, Inc. announced an exclusive agreement with Ostial Corporation to distribute the Flash Ostial System Dual Balloon Angioplasty Catheter in the United States. The Flash Ostial System is designed to help overcome the challenges of aorto-ostial stenting and compliments the Mynx(R) Product Family of Vascular Closure Devices to expand AccessClosure's portfolio. AccessClosure will showcase its growing portfolio of devices at booth 314 at the Vascular Interventional Advances 2013 (VIVA) this week in Las Vegas, NV, beginning when the exhibit hall opens at the Wynn Hotel.

Similar Private Companies By Industry

Company Name Region
Biomet 3i LLC United States
3Derm Systems, LLC United States
NuAire, Inc. United States
Vision Pointe Optical Inc. United States
MEDPROTECT LLC United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AccessClosure, Inc., please visit www.accessclosure.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.